Metabolomic Technologies Inc. is a privately held company developing metabolomics-based in vitro diagnostics for cancer and other diseases. Our lead product PolypDx™ is a urine-based screening test for the detection of adenomatous polyps and colorectal cancer.
Company Details
- Employees
- 3
- Founded
- -
- Address
- E116 - 2011 94 Street Nw, Edmonton,alberta T6n 1h1,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- metabolomictechnologies.ca
- Keywords
- Diagnostics, Metabolomics, Gastrointestinal Diseases, Colorectal Cancer, in-vitro diagnostics.
- HQ
- Edmonton, Alberta
Metabolomic Technologies Inc. Questions
Metabolomic Technologies Inc.'s website is metabolomictechnologies.ca
Metabolomic Technologies Inc.'s LinkedIn profile is https://ca.linkedin.com/company/metabolomic-technologies
Metabolomic Technologies Inc. has
3 employees.
View email and phone details for 3
employees at Metabolomic Technologies Inc..
Metabolomic Technologies Inc.'s industry is
Biotechnology Research
Metabolomic Technologies Inc.'s top competitors are
Screencancer As,
Ohm Oncology,
Pacylex Pharmaceuticals, Inc.,
Cytiva,
Thermo Fisher Scientific,
Translating Research In Elder Care (Trec),
Andante Biologics, Inc.,
Syantra Inc.,
Calgary Business Centre,
National Realty.
Metabolomic Technologies Inc.'s categories are Biotechnology Research
Metabolomic Technologies Inc.'s founding year is 2010
